- Home
- TXMD vs ZGM Comparison
TXMD vs ZGM Comparison
Compare TXMD & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | ZGM |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | Macau |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 26.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | TXMD | ZGM |
|---|---|---|
| Price | $2.49 | $2.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 121.4K | 16.6K |
| Earning Date | 03-26-2026 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.81 |
| EPS | 0.03 | ★ 0.10 |
| Revenue | $2,796,000.00 | ★ $3,163,046.00 |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $91.22 | ★ $21.44 |
| Revenue Growth | ★ 75.19 | 55.90 |
| 52 Week Low | $0.72 | $1.90 |
| 52 Week High | $2.95 | $4.51 |
Technical Indicators
Market Signals| Indicator | TXMD | ZGM |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 42.31 |
| Support Level | $2.12 | $2.00 |
| Resistance Level | $2.54 | $2.30 |
| Average True Range (ATR) | 0.27 | 0.26 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 36.78 | 15.00 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.